Sign In
Buy IRIX
$1.18
+0 (+0%)
At Close: Jun 23, 2026
Iridex Reports First Quarter 2024 Financial Results
04:05pm, Tuesday, 14'th May 2024
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and proc
Iridex's Strategic Review Process Should Bear Fruit 'Soon'
07:12pm, Thursday, 28'th Mar 2024
Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out in more than one transactio
IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript
07:30pm, Tuesday, 26'th Mar 2024
IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
07:06pm, Tuesday, 26'th Mar 2024
Iridex (IRIX) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.07 per share a year ago.
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Tuesday, 26'th Mar 2024
MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
04:05pm, Wednesday, 20'th Mar 2024
MOUNTAIN VIEW, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and p
3 Laser Systems Stocks to Watch in a Challenging Industry
10:20am, Wednesday, 21'st Feb 2024
The Zacks Laser Systems and Components industry participants like MicroVision (MVIS), Cutera (CUTR) and IRIDEX Corporation (IRIX) gain from solid demand for emerging applications like autonomous drivi
MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the first
MOUNTAIN VIEW, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment of eye diseases, proudly announces the US launc
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
06:00pm, Thursday, 28'th Dec 2023
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment
MOUNTAIN VIEW, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro
Iridex Reports Third Quarter 2023 Financial Results and Business Update
04:21pm, Tuesday, 14'th Nov 2023
MOUNTAIN VIEW, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
09:00am, Monday, 13'th Nov 2023
The Company also announced plans to present at Stifel Healthcare Conference The Company also announced plans to present at Stifel Healthcare Conference
Iridex to Report Third Quarter Financial Results on November 14, 2023
04:22pm, Thursday, 26'th Oct 2023
MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
Iridex: The Whole Is Less Than The Sum Of The Parts
05:04am, Wednesday, 04'th Oct 2023
IRIDEX Corporation is a leading provider of laser-based retinal treatments and is respected in the ophthalmic industry. IRIX stock has experienced a significant decline in value, but the primary reaso
